2008
DOI: 10.3109/s10165-008-0085-5
|View full text |Cite
|
Sign up to set email alerts
|

Tristetraprolin (TTP) gene polymorphisms in patients with rheumatoid arthritis and healthy individuals

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

2
12
0

Year Published

2010
2010
2024
2024

Publication Types

Select...
7

Relationship

0
7

Authors

Journals

citations
Cited by 18 publications
(14 citation statements)
references
References 9 publications
2
12
0
Order By: Relevance
“…Alternatively, the presence of this SNP could influence transcription or the stability of TTP mRNA [96]. More recently a single nucleotide polymorphism (SNP359A->G) was identified within the promoter region of TTP [97]. The functional consequence of this SNP was demonstrated to impact TTP promoter activity with the presence of the G allele resulting in approximately a 2-fold decrease in TTP promoter activity [97].…”
Section: The Role Of Tis11 Family Members In Diseasementioning
confidence: 99%
See 2 more Smart Citations
“…Alternatively, the presence of this SNP could influence transcription or the stability of TTP mRNA [96]. More recently a single nucleotide polymorphism (SNP359A->G) was identified within the promoter region of TTP [97]. The functional consequence of this SNP was demonstrated to impact TTP promoter activity with the presence of the G allele resulting in approximately a 2-fold decrease in TTP promoter activity [97].…”
Section: The Role Of Tis11 Family Members In Diseasementioning
confidence: 99%
“…More recently a single nucleotide polymorphism (SNP359A->G) was identified within the promoter region of TTP [97]. The functional consequence of this SNP was demonstrated to impact TTP promoter activity with the presence of the G allele resulting in approximately a 2-fold decrease in TTP promoter activity [97]. Although no significant differences were observed in the allele frequencies of SNP359A->G between healthy individuals and RA patients, a trend, although not statistically significant, was observed in patients with the GG genotype to have a younger age of disease onset compared to those with genotypes AA/AG [97].…”
Section: The Role Of Tis11 Family Members In Diseasementioning
confidence: 99%
See 1 more Smart Citation
“…We are not aware of any functional polymorphisms, mutations, or alternatively-spliced isoforms of PARP-14 in either mouse or human, but polymorphisms in the promoter and coding regions of TTP in humans have been linked to TTP expression levels and may influence risk or severity of cancer and inflammatory disorders such as rheumatoid arthritis. [48][49][50] In conclusion, our study establishes posttranscriptional regulation of TF mRNA as an important level of control of TF expression and raises the question as to what degree altered expression of TF in disease states relates to dysfunctional control of mRNA stability. We have discovered interactions between PARP-14, a new protein in posttranscriptional regulation, and TTP, an established protein (D-E) TF activity was measured in lung tissue and peripheral blood leukocytes using a turbimetric clotting assay (n 5 6-8 mice per group).…”
Section: Org Frommentioning
confidence: 99%
“…Between the two-genotype groups of rs17879933, BMI, SBP, DBP, UA, and TNF-α levels were significantly different, and the rs17879933 II genotype had higher values than the rs17879933 DD + ID genotype. Suzuki et al (2008) identified an SNP, namely SNP359 A/G (ZFP36 rs251864), within the ZFP36 promoter region that impacted promoter activity. Although no differences were observed in the allele frequencies of SNP359 A/G between healthy individuals and rheumatoid arthritis patients, the presence of the minor G allele inhibited ZFP36 promoter activity by approximately twofold compared with the A allele.…”
Section: Discussionmentioning
confidence: 99%